Annual report pursuant to Section 13 and 15(d)

Acquisition (Details Narrative)

v3.20.1
Acquisition (Details Narrative) - USD ($)
 12 Months Ended
Oct. 18, 2019
Jul. 15, 2019
Jun. 30, 2019
Dec. 31, 2019
Apr. 21, 2020
Dec. 31, 2018
Dec. 31, 2017
Cliam offset amoount       $ 735,000      
Expiration period of cliam       Jan. 15, 2020      
Payment settlement $ 6,024,489            
Indemnification holdback description       Any amounts due to the Company under the NWA were to be set off against the Excess Consideration Note and any amounts due to the Company under the ARA were to be either set off against the Excess Consideration Note or, if it is no longer outstanding, satisfied through an AR Holdback (as defined in the Asset Purchase Agreement) mechanism, in each case as further set forth in the Asset Purchase Agreement. Additionally, an indemnification holdback of $735,000 was established as an offset for any potential claims against the Company related to the transaction. The expiration period for the notification of any third-party claims was set at January 15, 2020. On October 18, 2019, a payment of $6,024,489 was made in settlement of the note less remaining holdbacks of $887,858, $735,000 for the Indemnification Holdback and $152,858 for the remaining AR Holdback. In March 2020, the Company reimbursed CGI for the full amount of the $887,858 holdbacks after its determination that the contractual obligations related to the holdbacks had been fully satisfied.      
Repayments of debt 887,858            
Goodwill   $ 8,300,000   $ 8,433,000  
Finite lived intangible assets   $ 7,300,000          
Finite lived intangible assets weighted-average amortization period   8 years 4 months 24 days          
Business transaction expenses   $ 2,500,000          
Trademarks [Member]              
Finite lived intangible assets weighted-average amortization period   10 years          
Customer Relationships [Member]              
Finite lived intangible assets weighted-average amortization period   8 years          
Subsequent Event [Member]              
Reimbursements amount         $ 735,000    
Indemnification Holdback [Member]              
Repayments of debt 735,000            
AR Holdback [Member]              
Repayments of debt $ 152,858            
CGI Bio Pharma [Member]              
Business combination consideration amount     $ 775,000        
Accounts receivable       $ 830,000      
Asset Purchase Agreement [Member] | Inital Tranche [Member]              
Payment of preferred stock financing   $ 13,800,000          
Asset Purchase Agreement [Member] | CGI Bio Pharma [Member]              
Assets and assumed certain liabilities   23,500,000          
Proceeds from debt   7,692,300          
Asset Purchase Agreement [Member] | CGI Bio Pharma [Member] | Base Purchase Price [Member]              
Assets and assumed certain liabilities   $ 1,980,000